全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:K C Lakshmaiah , K S Rachan Shetty ...
来源:[J].Journal of Cancer Research and Therapeutics(IF 0.761), 2015, Vol.11 (4), pp.857-861DOAJ
摘要:Background: Lenalidomide an immunomodulatory agent has shown activity in relapsed/refractory lymphoma. This study was conducted to evaluate its efficacy and optimal dose in Indian patients with relapsed/refractory lymphoma who were unable or unwilling to undergo autologous h...
作者:K C Lakshmaiah , K Govind Babu ...
来源:[J].Journal of Cancer Research and Therapeutics(IF 0.761), 2017, Vol.13 (1), pp.80-83DOAJ
摘要:Introduction: Bone metastasis is a rare site of metastasis, seen in only 3.7–11% of clinical cases. Isolated bone involvement has been reported very rarely in literature. Moreover, the patients who have bone metastasis at presentation are even rare.Objectives: To discuss the...
作者:K C Lakshmaiah , Linu A Jacob ...
来源:[J].Journal of Cancer Research and Therapeutics(IF 0.761), 2014, Vol.10 (3), pp.469-478DOAJ
摘要:Epigenetics is the study of heritable alterations in gene expression that are not accompanied by the corresponding change in DNA sequence. Three interlinked epigenetic processes regulate gene expression at the level of chromatin, namely DNA methylation, nucleosomal remodeling and...
作者:K C Lakshmaiah , Umesh Das ...
来源:[J].Journal of Cancer Research and Therapeutics(IF 0.761), 2014, Vol.10 (4), pp.945-950DOAJ
摘要:Background: Extra nodal involvements of non-Hodgkin′s lymphomas (NHL) are not so uncommon, but the involvement of oral cavity by NHL is very rare.Materials and Methods: The present study involved retrospective analysis of patients from year 2001 to 2011, who presented with o...
作者:K C Lakshmaiah , Lokanatha Dasappa ...
来源:[J].South Asian Journal of Cancer, 2018, Vol.7 (1), pp.11-15DOAJ
摘要:Background: Health-related quality of life (HRQOL) is an important oncologic end point for upper gastrointestinal malignancies. Unfortunately, till date, there is no published prospective data from India, comparing the HRQOL parameters between first-line chemotherapy regimen...
作者:... Geetha Vikram Patil Okaly , K C Lakshmaiah , S Krishnamurthy
来源:[J].South Asian Journal of Cancer, 2018, Vol.7 (1), pp.7-10DOAJ
摘要:Aim: The aim of the study was to analyze the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) status over 7 years in South Indian women with breast cancer. Further analysis of a subgroup was done to study clinically defi...
作者:... Pretesh R Kiran , K C Lakshmaiah , D Lokanatha
来源:[J].Lung India, 2017, Vol.34 (2), pp.176-178DOAJ
摘要:Multiple myeloma (MM) is a plasma cell neoplasm and constitutes 10% of hematologic malignancies. Malignant myelomatous pleural effusions are very rare and occur in <1% of cases of MM. In this article, we report a rare case of a patient who initially presented with pleural effusio...
作者:K C Lakshmaiah , K Govind Babu ...
来源:[J].South Asian Journal of Cancer, 2017, Vol.6 (2), pp.72-74DOAJ
摘要:Introduction: Diffuse large B-cell lymphoma (DLBCL) is the most frequent non-Hodgkins lymphoma in the elderly. With the rising proportion of older persons in India, it is important to study current patterns and management of this disease, given that data in this regard are s...
作者:K C Lakshmaiah , K Govind Babu ...
来源:[J].Lung India, 2016, Vol.33 (2), pp.154-158DOAJ
摘要:Background: The incidence of lung cancer is rising in developing countries like India. Due to unaffordability among the low socioeconomic status (SES) patients, there is a significant delay in seeking appropriate medical treatment due to which a high proportion of patients p...
作者:K C Lakshmaiah , Ankit Agarwal ...
来源:[J].South Asian Journal of Cancer, 2017, Vol.6 (2), pp.69-71DOAJ
摘要:Introduction: Plasmablastic lymphoma (PBL) is a rare lymphoma associated with immunosuppression. It is strongly associated with immunosuppression (human immunodeficiency virus [HIV]) and often occurs within the oral cavity. PBL is also seen in patients receiving immunosuppre...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×